Literature DB >> 19290011

Medical care of overweight children under real-life conditions: the German BZgA observation study.

T Reinehr1, U Hoffmeister, R Mann, C Goldapp, J Westenhöfer, A Egmond-Froehlich, M Bullinger, U Ravens-Sieberer, R W Holl.   

Abstract

OBJECTIVE: Current care for overweight children is controversial, and only few data are available concerning the process of care, as well as the outcome under real-life conditions.
METHODS: A nationwide survey of treatment programs for overweight children and adolescents in Germany identified 480 treatment centers. From 135 institutions that had agreed to participate in this study of process of care and outcome, 48 randomly chosen institutions were included in the study. All 1916 overweight children (mean age 12.6 years, 57% female, mean body mass index 30.0 kg/m(2)), who presented at these institutions for lifestyle interventions, were included in this study. Diagnostic procedures according to guidelines and effect of lifestyle interventions on weight status at end of treatment were analyzed.
RESULTS: Children treated <3 months were older and more obese, whereas children with >3 months treatment duration demonstrated more cardiovascular risk factors at baseline. On the basis of an intention-to-treat analysis, 75% of the children reduced their overweight. The reduction of overweight varied widely between the treatment institutions (intracluster correlation coefficient 0.15 in the multiple regression model reflecting the intracenter correlation). Screening for hypertension, disturbed glucose metabolism and dyslipidemia was performed in 52% of the children at baseline and in 10% at the end of intervention.
CONCLUSION: Overweight reduction is achievable with lifestyle intervention in clinical practice. However, because the clientele, treatment approach and outcome varied widely between different institutions, and screening for comorbidities was seldomly performed as recommended, quality criteria for institutions have to be implemented to improve medical care of overweight children under real-life conditions.

Entities:  

Mesh:

Year:  2009        PMID: 19290011     DOI: 10.1038/ijo.2009.50

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  6 in total

Review 1.  Lifestyle intervention in childhood obesity: changes and challenges.

Authors:  Thomas Reinehr
Journal:  Nat Rev Endocrinol       Date:  2013-07-30       Impact factor: 43.330

2.  Energy Management for Personalized Weight Reduction (EMPOWER) Program: Three-Year Outcome Data.

Authors:  A P Vidmar; C Fink; B Torres; B Manzanarez; S D Mittelman; C P Wee; C Borzutzky
Journal:  Adv Clin Endocrinol Metab       Date:  2019-03-10

3.  Evaluation of the role of Care Sport Connectors in connecting primary care, sport, and physical activity, and residents' participation in the Netherlands: study protocol for a longitudinal multiple case study design.

Authors:  E Smit; K E F Leenaars; M A E Wagemakers; G R M Molleman; M A Koelen; J van der Velden
Journal:  BMC Public Health       Date:  2015-11-23       Impact factor: 3.295

4.  The influence of familial predisposition to cardiovascular complications upon childhood obesity treatment.

Authors:  Louise A Nielsen; Christine Bøjsøe; Julie T Kloppenborg; Cæcilie Trier; Michael Gamborg; Jens-Christian Holm
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

5.  Screening for co-morbidity in 65,397 obese pediatric patients from Germany, Austria and Switzerland: adherence to guidelines improved from the year 2000 to 2010.

Authors:  Marion Flechtner-Mors; Susanna Wiegand; Ines Gellhaus; Heidi Siefken-Kaletka; Kurt Widhalm; Thomas Reinehr; Hans-Peter Roost; Georg Leipold; Ulrike Hoffmeister; Reinhard W Holl
Journal:  Obes Facts       Date:  2013-08-17       Impact factor: 3.942

6.  Clinical and metabolic effect of a multidisciplinary intervention through a comprehensive care program for children and adolescents with obesity

Authors:  Nora Alejandra Zuluaga; Adriana Osorno; Alba Lozano; Oscar Villada
Journal:  Biomedica       Date:  2020-03-01       Impact factor: 0.935

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.